tiprankstipranks
Trending News
More News >
Science Applications International Corp. (SAIC)
NASDAQ:SAIC

Science Applications (SAIC) AI Stock Analysis

Compare
703 Followers

Top Page

SAIC

Science Applications

(NASDAQ:SAIC)

Select Model
Select Model
Select Model
Neutral 64 (OpenAI - 5.2)
Rating:64Neutral
Price Target:
$93.00
▲(6.19% Upside)
Action:ReiteratedDate:02/18/26
SAIC scores as a moderate-quality opportunity: financial fundamentals are solid (profitability, cash conversion, improving leverage) and valuation is supportive, but the stock’s technical picture is weak and recent results/guidance point to ongoing revenue pressure despite improving margins and strong cash flow.
Positive Factors
Improving margins and cash conversion
SAIC has sustained operating efficiency with improving net margins and strong operating-cash-flow-to-net-income conversion. That structural profitability supports reinvestment, debt reduction and shareholder capital returns, cushioning the business through top-line cyclicality.
Strong bookings and multi‑year awards
A book-to-bill above 1 and recent multi‑year Defense awards indicate a durable backlog of contracted work. Multi-year government contracts create predictable revenue streams, support utilization and enable long-term planning despite near-term procurement timing swings.
Accretive M&A and cost-efficiency actions
SilverEdge and targeted $100M+ efficiency measures are structural moves to lift margins and improve competitive differentiation on bids. Accretive M&A plus reinvestment into higher-ROI areas can sustainably boost EBITDA and long-term EPS if integration and capture execution hold.
Negative Factors
Recent revenue contraction
SAIC faces a durable top-line headwind: recent quarters show revenue declines and guidance implies limited organic growth. Prolonged revenue weakness constrains operating leverage, makes margin gains harder to sustain, and raises pressure on management to convert pipeline into funded wins.
Weak capture and BD execution
Persistent shortcomings in capture and business development reduce the ROI from investments in technology and innovation. If SAIC cannot reliably convert proposals into awards, long-term revenue and EBITDA growth will be limited despite margin and efficiency initiatives.
Exposure to procurement delays and commoditized programs
Dependence on government procurement cycles and commoditized enterprise IT work makes revenue lumpy and sensitive to shutdowns, weather and award timing. Structural exposure to lower‑value, competitive programs pressures top-line resilience and strategic upward margin mobility.

Science Applications (SAIC) vs. SPDR S&P 500 ETF (SPY)

Science Applications Business Overview & Revenue Model

Company DescriptionScience Applications International Corporation provides technical, engineering, and enterprise information technology (IT) services primarily in the United States. The company's offerings include engineering; technology integration; IT modernization; maintenance of ground and maritime systems; logistics; training and simulation; operation and program support services; and end-to-end services, such as design, development, integration, deployment, management and operations, sustainment, and security of its customers' IT infrastructure, as well as cloud migration, managed services, infrastructure modernization, and enterprise IT-as-a-service solutions. It serves the U.S. military comprising Army, Air Force, Navy, Marines, and Coast Guard; Department of Defense agencies; National Aeronautics and Space Administration; the U.S. Department of State; Department of Justice; Department of Homeland Security; and various intelligence community agencies, as well as U.S. federal civilian agencies. The company was formerly known as SAIC Gemini, Inc. and changed its name to Science Applications International Corporation in September 2013. Science Applications International Corporation was founded in 1969 and is headquartered in Reston, Virginia.
How the Company Makes MoneySAIC generates revenue primarily through government contracts, particularly with the Department of Defense and various federal agencies. The company's revenue model is built around providing technical services, systems engineering, and IT solutions, often under multi-year contracts that ensure a steady stream of income. Key revenue streams include consulting services, software development, and maintenance contracts. Additionally, SAIC benefits from partnerships with leading technology firms and defense contractors, allowing it to enhance its service offerings and expand its market reach. The company's focus on emerging technologies, such as artificial intelligence and cloud services, further contributes to its earnings by tapping into growing market demands.

Science Applications Key Performance Indicators (KPIs)

Any
Any
Total Backlog
Total Backlog
Chart Insights
Data provided by:The Fly

Science Applications Earnings Call Summary

Earnings Call Date:Dec 04, 2025
(Q3-2026)
|
% Change Since: |
Next Earnings Date:Mar 16, 2026
Earnings Call Sentiment Neutral
The call reflected a mixed performance with promising developments through the acquisition of SilverEdge and strong business development results, while grappling with revenue decline and execution challenges in business development. However, the proactive steps towards cost efficiency and margin improvement suggest a positive outlook.
Q3-2026 Updates
Positive Updates
Acquisition of SilverEdge
The acquisition of SilverEdge is expected to be accretive next year, pushing margins up and being accretive on EPS. It will enhance the differentiation of bids not just within the intelligence community but across the broader portfolio.
Strong Business Development Results
3Q net bookings of $2.2 billion resulted in a book-to-bill ratio of 1.2x. Major awards included a five-year recompete with the Air Force ($1.4 billion) and a five-year $413 million contract with the US Army.
Improved Financial Performance
Adjusted diluted EPS was $2.58, reflecting strong margin performance and a favorable tax rate. Free cash flow for the third quarter was $135 million, with expectations of greater than $550 million for FY '26 and over $600 million for FY '27.
Cost Efficiency Initiatives
Identified over $100 million in annual spend to be reinvested in higher ROI areas to drive growth and increase margins. Efforts include implementing efficiencies across shared services and other indirect functions.
Negative Updates
Decline in Third-Quarter Revenue
Third-quarter revenue declined by 5.6% year over year, impacted by a government shutdown which contributed to a one-point headwind.
Civil Segment Decline
The civil segment experienced a 7% year-on-year decline during the quarter. This was attributed to seasonality and lumpiness, although nine-month performance was flat with improved margins.
Challenges in Business Development Execution
Science Applications International Corporation has struggled to convert innovation into revenue and EBITDA growth due to below-average business development and capture performance.
Company Guidance
During the Science Applications International Corporation (SAIC) fiscal year 2026 Q3 earnings call, the company provided updated financial guidance, revealing several key metrics. Third-quarter revenue was reported at $1.87 billion, marking a 5.6% decline year-over-year, partly due to a government shutdown impact. Adjusted EBITDA reached $185 million, yielding a margin of 9.9%, and adjusted diluted EPS was $2.58. The company generated a strong free cash flow of $135 million despite shutdown-related challenges. SAIC's updated guidance for fiscal year 2026 includes a minor revenue increase to account for the SilverEdge acquisition, with a reaffirmation of organic growth targets. The fiscal year 2026 adjusted EBITDA margin guidance was increased by 10 basis points, and adjusted EPS guidance was raised by $0.04, assuming a 10% effective tax rate. Looking ahead to fiscal year 2027, SAIC projects a 0% to 3% organic revenue growth, with a slight increase in revenue guidance due to recent acquisitions and business wins. The company also expects to repurchase approximately $1 billion of shares over fiscal years 2026 and 2027, representing about 25% of its market value.

Science Applications Financial Statement Overview

Summary
Solid profitability and operating efficiency (improving net margin; healthy EBIT/EBITDA), improving leverage and strong ROE, and good cash conversion. Offsetting this, recent revenue and free-cash-flow growth have been negative, signaling top-line and cash growth pressure.
Income Statement
72
Positive
Science Applications has demonstrated stable profitability with a consistent gross profit margin around 11.9% and a net profit margin improving to 5.3% in the TTM period. However, the revenue growth rate has been negative recently, indicating a potential challenge in expanding sales. EBIT and EBITDA margins remain healthy, reflecting efficient operational management.
Balance Sheet
65
Positive
The company's debt-to-equity ratio has improved significantly in the TTM period, reducing from previous high levels, which indicates a positive trend in managing leverage. Return on equity remains strong at 25.7%, showcasing effective use of equity to generate profits. However, the equity ratio is not provided, limiting a full assessment of financial stability.
Cash Flow
68
Positive
Operating cash flow to net income ratio is strong, indicating good cash generation relative to reported earnings. However, free cash flow growth has been negative in the TTM period, which could signal potential cash flow challenges. The free cash flow to net income ratio remains robust, suggesting efficient cash management.
BreakdownTTMJan 2025Jan 2024Jan 2023Jan 2022Jan 2021
Income Statement
Total Revenue7.35B7.48B7.44B7.70B7.39B7.06B
Gross Profit883.00M892.00M872.00M888.00M859.00M792.00M
EBITDA663.00M694.00M882.00M650.00M628.00M572.00M
Net Income371.00M362.00M477.00M300.00M277.00M209.00M
Balance Sheet
Total Assets5.42B5.25B5.31B5.54B5.75B5.72B
Cash, Cash Equivalents and Short-Term Investments45.00M56.00M94.00M109.00M106.00M171.00M
Total Debt2.81B2.39B2.25B2.53B2.71B2.72B
Total Liabilities3.91B3.67B3.53B3.84B4.12B4.17B
Stockholders Equity1.51B1.58B1.78B1.69B1.62B1.54B
Cash Flow
Free Cash Flow459.00M458.00M369.00M507.00M482.00M709.00M
Operating Cash Flow466.00M494.00M396.00M532.00M518.00M755.00M
Investing Cash Flow-257.00M-35.00M314.00M-36.00M-292.00M-1.23B
Financing Cash Flow-210.00M-498.00M-725.00M-493.00M-301.00M464.00M

Science Applications Technical Analysis

Technical Analysis Sentiment
Negative
Last Price87.58
Price Trends
50DMA
100.87
Negative
100DMA
97.12
Negative
200DMA
103.96
Negative
Market Momentum
MACD
-4.35
Positive
RSI
37.89
Neutral
STOCH
40.07
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SAIC, the sentiment is Negative. The current price of 87.58 is below the 20-day moving average (MA) of 93.95, below the 50-day MA of 100.87, and below the 200-day MA of 103.96, indicating a bearish trend. The MACD of -4.35 indicates Positive momentum. The RSI at 37.89 is Neutral, neither overbought nor oversold. The STOCH value of 40.07 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SAIC.

Science Applications Risk Analysis

Science Applications disclosed 30 risk factors in its most recent earnings report. Science Applications reported the most risks in the "Legal & Regulatory" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Science Applications Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
75
Outperform
$1.78B24.388.18%0.80%6.98%-4.56%
73
Outperform
$6.54B11.9922.37%1.41%7.40%-14.45%
72
Outperform
$12.94B25.0913.18%12.61%11.85%
72
Outperform
$22.01B15.4431.05%0.87%6.48%22.17%
64
Neutral
$3.95B11.0323.75%1.69%-0.38%31.38%
61
Neutral
$37.18B12.37-10.20%1.83%8.50%-7.62%
53
Neutral
$2.63B11.1121.77%-1.90%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SAIC
Science Applications
87.58
-11.86
-11.92%
CACI
Caci International
586.02
254.96
77.01%
FORTY
Formula Systems
117.50
23.59
25.12%
G
Genpact
37.94
-14.15
-27.17%
LDOS
Leidos Holdings
174.13
45.85
35.74%
KD
Kyndryl Holdings Incorporation
11.65
-26.82
-69.72%

Science Applications Corporate Events

Business Operations and StrategyExecutive/Board Changes
Science Applications Names Jim Reagan as Permanent CEO
Positive
Feb 17, 2026

On February 17, 2026, SAIC’s board appointed James “Jim” C. Reagan as chief executive officer, making permanent a role he had held on an interim basis since October 23, 2025. Reagan, 67, brings nearly four decades of experience, including senior finance and transformation roles at Leidos, Vencore, PAE and other telecom and technology firms, and has served on SAIC’s board since 2023.

His CEO compensation package includes a $1.2 million base salary, a target bonus equal to 150% of salary, and $7.5 million in long‑term equity incentives split between restricted and performance stock units, aligning his pay with shareholder returns. SAIC’s board highlighted Reagan’s steady leadership during the interim period and his work with business leaders to drive innovation, speed and efficiency, signaling a push for sustained, profitable growth and sharper competitive positioning in government technology and services.

The most recent analyst rating on (SAIC) stock is a Sell with a $82.00 price target. To see the full list of analyst forecasts on Science Applications stock, see the SAIC Stock Forecast page.

Business Operations and StrategyFinancial Disclosures
SAIC Cuts Revenue Outlook But Boosts Profitability Guidance
Negative
Feb 11, 2026

On February 11, 2026, SAIC issued preliminary unaudited results for its fiscal fourth quarter and full year 2026, alongside revised guidance for fiscal 2027, citing procurement delays, a 2025 U.S. government shutdown, adverse weather and unfavorable customer award decisions that are weighing on revenue. For fiscal 2026 it now expects about $7.26 billion in revenue, modestly below prior guidance, but stronger profitability with adjusted EBITDA of roughly $705 million, a margin of 9.7%, higher adjusted EPS and free cash flow above earlier expectations.

Management acknowledged that recent revenue pressures are concentrated in larger, commoditized enterprise IT programs and said the company will shift toward opportunities with greater technology transformation and execution upside. Updated fiscal 2027 guidance now calls for revenue of $7.0–$7.2 billion and an organic decline of 2–4%, down from a prior outlook of flat to modest growth, while adjusted EBITDA of $705–$715 million and margin of 9.9–10.1% reflect improved efficiency and mix, suggesting SAIC aims to defend profitability and cash generation despite a weaker top line.

The most recent analyst rating on (SAIC) stock is a Buy with a $122.00 price target. To see the full list of analyst forecasts on Science Applications stock, see the SAIC Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Feb 18, 2026